Are you Dr. Breneman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 47 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3130 Highland Ave
Cincinnati, OH 45219Phone+1 513-584-3686Fax+1 513-475-7636
Summary
- Dr. Debra Breneman, MD is a board certified dermatologist in Cincinnati, Ohio. She is currently licensed to practice medicine in Ohio and Iowa. She is affiliated with University of Cincinnati Medical Center, Good Samaritan Hospital, and Mercy Health - Anderson Hospital.
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Dermatology, 1982 - 1985
Corewell Health – Grand Rapids/Michigan State UniversityInternship, Internal Medicine, 1981 - 1982
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1981
Certifications & Licensure
OH State Medical License 1985 - 2025
IA State Medical License 1985 - 1999- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis Start of enrollment: 2007 May 07
- A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP) Start of enrollment: 2007 Jul 01
Publications & Presentations
PubMed
- 56 citationsCetirizine versus Hydroxyzine and Placebo in Chronic Idiopathic UrticariaDebra L. Breneman
The Annals of Pharmacotherapy. 1996-10-01 - 95 citationsTopical capsaicin for treatment of hemodialysis-related pruritusDebra L. Breneman, J. Scott Cardone, Renee F. Blumsack, Ronald M. Lather, Edward A. Searle
Journal of the American Academy of Dermatology. 1992-01-01 - 6 citationsPhase II clinical trial of bexarotene gel 1% in psoriasis.Debra L. Breneman, Pranav Sheth, Vivian Berger, Vahid Naini, Victor Stevens
Journal of Drugs in Dermatology. 2007-05-01
Press Mentions
UC Team Treats a Rare Form of Skin CancerJanuary 8th, 2016
Professional Memberships
- Fellow
